Journal Browser

Go Edit a Special Issue

Archive

Special Issue Title:

Therapy and prognosis of metastatic prostate cancer

Deadline for manuscript submissions: 31 August 2021

Print Special Issue Flyer (21)

Special Issue Editor

  • Guest Editor

    Kullmann TamásE-MailWebsite

    PhD, Department of Oncology, Petz Aladár Hospital, Győr, Hungary

    Interests: Infections and malignancies of the urinary tract, Diagnosis of “fever of unknown origin”, Oncologic emergencies, Pain relief for cancer patients

Special Issue Information

Dear Colleagues,


Please let me invite you to contribute to the preparation and later to favour a mindful lecture of this speciel issue of the Journal of Men’s Health dedicated to metastatic prostate cancer.


Although being a leading cause of cancer death, metastatic prostate cancer, compared to other cancer types, is any longer necesserily a life threatening condition. Thanks to recent pharmaceutical developments, several lines of anti-hormonal and cytostatic treatments may provide long years of disease control.


We would like to focus in this special issue to the diagnostic challenges, to the proper use of innovative therapies and to the patients’ perspectives open with the improved prognosis. Differentiating between localised and generalised disease remains problematic even with the best imaging techniques. Sequencing and maintenance of novel drugs are being debated. The men’s own evaluation of the quality of their prolonged life is maybe not enough taken into account.


This special issue offers an opportunity to address the following but other topics:

- Diagnosis and treatment of oligometastatic disease

- Diagnosis and treatment of micrometastatic disease

- Diagnosis and treatment of neuroendocrin cancer of the prostate

- Optimal selection of systemic therapies

- Optimal maintenance of second line antiandrogenic therapies

- Optimal comedication of androgen synthesis inhibitors

- Optimal dosing of bisphosphonates

- Quality of life of patients with metastatic prostate cancer


Let’s share our experience to the better care of the patients of all of us.


Yours,

Kullmann Tamás

Keywords

Prostate cancer, Metastatic prostate cancer, Diagnosis, Treatment, Prognosis, Quality of life, Oligometastatic disease, Micrometastatic disease, Androgen synthesis inhibitors, Second line antiandrogenic therapies, Bisphosphonates

Manuscript Submission Information

Submissions will be accepted on a rolling basis and reviewed by experts in the field. Rapid peer review and prompt editorial decisions will ensure that quality manuscripts are published on time. The manuscript has not already been published or submitted elsewhere (except conference proceedings papers). If similar work has been published or submitted elsewhere, you must provide a copy of the submitted manuscript. You may not submit your manuscript elsewhere while it is under consideration at the Journal of Men's Health. All manuscripts undergo thorough double-blind peer-review. To check the suitability of the special issue for publishing your manuscript, please read the journal's aims and scope and read or download the guide for authors. You may also send a brief abstract of your work (about 100 words) to the Editorial Office at editor@jomh.org. A guide for authors and other relevant information for manuscript submission is available on the Instructions for Authors page.

Academic Writing and English Language Editing Services

Authors who feel that their manuscript may benefit from additional academic writing or language editing support before submission are strongly encouraged to use academic editing services.

Article Processing Charges (APC)

All manuscripts submitted to the Journal of Men's Health are assessed according to the journal standard editorial criteria. If accepted for publication, an Article Processing Charge of 900 USD applies.

The journal typically offers a 30% discount to submissions with good quality invited by the Editor-in-Chief, Guest Editor (GE) and Editorial Board Member.

Lower-income countries ( World Bank classification ) may apply a further discount or waiver (please contact editor@jomh.org when submit).

Type of Articles: Original Research, Review, Mini-Review, Systematic Review, Short Communication, Case Report, Letter to the Editor, Commentary, Rapid Report, Meeting Report, News and Views

Share This Special Issue

Published Papers (6 papers)

Open Access Special Issue

A comprehensive mechanistic basis of prostate cancer advancement & its personalized implementation-bridging the gap: present state and future prospect

Dipamoy Datta,Md Aftabuddin,Raja Kundu,Mayank Baid,Sanjoy Kumar Das,Supriti Sarkar,Suresh Bajoria,Tapan Kumar Mandal,Pragnadyuti Mandal,Chandan Banerjee,B Shiva Shankar,Anish Banerjee,Chinmay Kumar Panda,Sougata Sarkar,Nilkantha Garain,Subrata Chakraborty,Anirban Sinha,Chaitali Banerjee,Losiana Nayak,Aniruddha Bagchi,Subhadra Roy,Kaushik Goswami,Leena Kumari

DOI: 10.31083/jomh.2021.029

Abstract ( 506 ) PDF (181.62 kB) ( 179 )

Open Access Special Issue

Enzalutamide versus Abiraterone Acetate as first-line treatment of castration resistant metastatic prostate cancer in geriatric (≥75) patients

Ali Alkan,Zeynep Gülsüm Güç,Mustafa Gürbüz,Güliz Özgün,Serkan Değirmencioğlu,Mutlu Doğan,Tuğba Akın Telli,Özge Keskin,Çağatay Arslan,Burak Bilgin,Sema Sezgin Göksu,Hacer Demir,Elif Berna Köksoy,Osman Köstek,İsmail Ertürk,Teoman Şakalar,Arzu Yaşar,Görkem Türkkan,Büşra Kasım,Aziz Karaoğlu,Berna Çakmak Öksüzoğlu,Fulden Yumuk,Mehmet Ali Şendur,Hasan Şenol Coşkun,İrfan Çiçin,Nuri Karadurmuş,Özgür Tanrıverdi,Hakan Akbulut,Yüksel Ürün

Online publish date: 02 June 2021

DOI: 10.31083/jomh.2021.041

Abstract ( 396 ) PDF (189.11 kB) ( 180 )

Open Access Special Issue

The 100 most-cited articles in castration-resistant prostate cancer: a bibliometric analysis

Hui Fang,Lugeng He,Huadong He,Xuliang Wang,Yuyong Wang,Hongwei Ge,Yuehua Wan,Chao Chen

Online publish date: 18 June 2021

DOI: 10.31083/jomh.2021.053

Abstract ( 370 ) PDF (2.66 MB) ( 165 )

Open Access Special Issue

Insights into association between urolithiasis and prostate cancer

Xiaolu Sun,Bhuman Deep Kour,Xiangtao Wang,Xiufang Hu,Yufen Wang,Sugunakar Vuree

Online publish date: 14 July 2021

DOI: 10.31083/jomh.2021.070

Abstract ( 368 ) PDF (1.56 MB) ( 156 )

Open Access Special Issue

The diagnostic value of a new formula combining age and prostate volume in prostate cancer

Xiaobo Yang,Jiahao Shan,Qiang Zhang,Zhongyu Yuan,Haoran Xu,Ziyang Liu,Xiaojie Zhou,Wenzhuo Ma,Hongbin Shi

Online publish date: 22 July 2021

DOI: 10.31083/jomh.2021.080

Abstract ( 312 ) PDF (1.5 MB) ( 156 )

Open Access Special Issue

Predictors of annual prostate-specific antigen (PSA) screening among black men: results from an urban community-based prostate cancer screening program

Marquita W. Lewis-Thames,Saira Khan,Veronica Hicks,Bettina F. Drake

Online publish date: 30 July 2021

DOI: 10.31083/jomh.2021.081

Abstract ( 219 ) PDF (152.26 kB) ( 150 )

Abstracted / indexed in

Science Citation Index Expanded Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Social Sciences Citation Index Social Sciences Citation Index contains over 3,400 journals across 58 social sciences disciplines, as well as selected items from 3,500 of the world’s leading scientific and technical journals. More than 9.37 million records and 122 million cited references date back from 1900 to present.

Current Contents - Social & Behavioral Sciences Current Contents - Social & Behavioral Sciences provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in the social and behavioral sciences.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

SCOPUS Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

DOAJ DOAJ is a community-curated online directory that indexes and provides access to high quality, open access, peer-reviewed journals.

CrossRef Crossref makes research outputs easy to find, cite, link, assess, and reuse. Crossref committed to open scholarly infrastructure and collaboration, this is now announcing a very deliberate path.

Portico Portico is a community-supported preservation archive that safeguards access to e-journals, e-books, and digital collections. Our unique, trusted process ensures that the content we preserve will remain accessible and usable for researchers, scholars, and students in the future.

Submission Turnaround Time

Conferences